课题基金 / 基金详情

PROMISing development for standardising the assessment of self-reported health worldwide? An exploration of the potential application of U.S. developed patient-reported outcome measures to Germany

PROMISing development for standardising the assessment of self-reported health worldwide? An exploration of the potential application of U.S. developed patient-reported outcome measures to Germany
全球自我报告健康评估标准化的发展前景如何?
批准号:
317400733
负责人:
Privatdozentin Dr. Sandra Nolte, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patient-reported outcomes (PROs) are of growing importance in the assessment of benefits and harms of medical interventions. As observers (proxy) do not accurately capture the patient perspective, regulatory authorities worldwide recommend the application of PROs in clinical trials. However, for these data to be used for comparative purposes across studies and crucial subgroups, it is imperative to develop standards for the assessment of self-reported health. Recent publications in this field recommend crosswalk tables or a calibration of different instruments on the same, a common, metric, which is a ground-breaking step towards standardised assessment of PROs. A major pioneer in the context of standardised PRO assessment is the Patient-Reported Outcomes Measurement Information System (PROMIS®) initiative, launched in 2004 by the U.S. National Institutes of Health. PROMIS is based on the idea that items measuring the same construct can be merged in one item bank and calibrated on the same metric. Since its launch, PROMIS researchers have developed and largely validated over 50 item banks. In 2012, PROMIS started expanding its efforts to other countries, which is a unique opportunity to standardise PROs worldwide. However, it comes with a range of challenges that need to be explored before item banks can be launched globally. These challenges relate to (1) cultural adequacy, (2) unidimensionality and generalisability, (3) transferability of U.S. item parameters to other language versions, and (4) applicability of reference data based on the U.S. general population for norming purposes. As a result, this proposal aims at a thorough testing of PROMIS items, using the PROMIS Physical Function (PF) Item Bank as an example. Specifically, to answer research question (1), the PF items are tested qualitatively. To explore (2) and (3), PROMIS items are tested in n=600 patients from three clinical samples (rheumatology, cardiology, psychosomatic medicine). First, confirmatory factor analyses explore unidimensionality of the construct. Second, tests of differential item functioning (DIF) explore generalisability (disease group-DIF), and third, new item parameter estimates derived from the German data explore transferability of the U.S. item parameters to the translated version (language-DIF). Finally, to answer (4), reference data from the German general population are obtained (n=1,000). The overarching aim of the present project is to make a fundamental contribution to answering some of the remaining psychometric challenges involved with the translation and cultural adaptation of items aimed at measuring self-reported health. This study shall make an important contribution to the standardisation of PRO assessment not only in Germany, but it shall contribute to the international body of knowledge of the assessment of subjective well-being.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1177/0269215517714297
发表时间: 2018-01-01
期刊: CLINICAL REHABILITATION
影响因子: 3
作者: [Liegl, Gregor, Rose, Matthias, Nolte, Sandra]
通讯作者: Nolte, Sandra
国内基金
海外基金
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
  • 批准号:
    82371668
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    乔云波
  • 依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
  • 批准号:
    82371276
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    严佳
  • 依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位: